Janet Rose Rea
Chief Operating Officer at Ave Maria Biotechnology LLC
Profile
Janet Rose Rea is currently the Chief Operating Officer at Ave Maria Biotechnology LLC.
Previously, she worked as the VP-Regulatory Affairs, Quality & Clinical Affairs at Atossa Therapeutics, Inc. from 2015 to 2020.
She also served as an Assistant Clinical Professor at the University of Washington.
Ms. Rea completed her undergraduate and graduate degrees at the University of Washington.
Janet Rose Rea active positions
| Companies | Position | Start |
|---|---|---|
Ave Maria Biotechnology LLC
 Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Chief Operating Officer | 08/07/2020 |
Former positions of Janet Rose Rea
| Companies | Position | End |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | General Counsel | 01/07/2020 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Training of Janet Rose Rea
| University of Washington | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |
- Stock Market
- Insiders
- Janet Rose Rea
